Invention Grant
US09327114B2 User-activated self-contained co-packaged iontophoretic drug delivery system
有权
用户激活的自给式共包封离子电渗药物输送系统
- Patent Title: User-activated self-contained co-packaged iontophoretic drug delivery system
- Patent Title (中): 用户激活的自给式共包封离子电渗药物输送系统
-
Application No.: US13802156Application Date: 2013-03-13
-
Publication No.: US09327114B2Publication Date: 2016-05-03
- Inventor: Terri B. Sebree , Robert P. Stathopulos , Mihai A. Vinatoru
- Applicant: Teva Pharmaceuticals International GmbH
- Applicant Address: CH Rapperswil-Jona
- Assignee: Teva Pharmaceuticals International GmbH
- Current Assignee: Teva Pharmaceuticals International GmbH
- Current Assignee Address: CH Rapperswil-Jona
- Agency: McCarter & English, LLP
- Agent Danielle L. Herritt
- Main IPC: A61N1/30
- IPC: A61N1/30 ; A61M31/00 ; A61N1/04 ; A61N1/32
Abstract:
A user-activated self-contained co-packaged iontophoretic drug delivery system and method of use for treatment of a subject are described.
Public/Granted literature
- US20130296766A1 USER-ACTIVATED SELF-CONTAINED CO-PACKAGED IONTOPHORETIC DRUG DELIVERY SYSTEM Public/Granted day:2013-11-07
Information query
